|
1
|
Dorobăţ CM, Haliciu AM and Bejan C:
Interdisciplinary correlations regarding the clinical and
paraclinical evaluations in HIV-positive pregnant women. Rev Med
Chir Soc Med Nat Iasi. 3:749–752. 2014.PubMed/NCBI
|
|
2
|
Sharp PM and Hahn BH: Origins of HIV and
the AIDS Pandemic. Cold Spring Harb Perspect Med.
1(a006841)2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Smith JH and Whiteside A: The history of
AIDS exceptionalism. J Int AIDS Soc. 13(47)2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Wainberg MA and Jeang KT: 25 years of
HIV-1 research-progress and perspectives. BMC Med.
6(31)2008.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Greene WC: A history of AIDS: Looking back
to see ahead. Eur J Immunol. 37 (Suppl 1):S94–S102. 2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Pau AK and George JM: Antiretroviral
therapy: Current drugs. Infect Dis Clin North Am. 3:371–402.
2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fanales-Belasio E, Raimondo M, Suligoi B
and Buttò S: HIV virology and pathogenetic mechanisms of infection:
A brief overview. Ann Ist super Sanità. 1:5–14. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lu DY, Wu HY, Yarla NS, Xu B, Ding J and
Lu TR: HAART in HIV/AIDS treatments: Future trends. Infect Disord
Drug Targets. 1:15–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Barbaro G: Cardiovascular manifestations
of HIV infection. J R Soc Med. 8:384–90. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Prendergast BD: HIV and cardiovascular
medicine. Heart. 7:793–800. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hajjar LA, Calderaro D, Yu PC, Giuliano I,
Lima EM, Barbaro G and Caramelli B: Cardiovascular manifestations
in patients infected with the human immunodeficiency virus. Arq
Bras Cardiol. 5:363–377. 2005.PubMed/NCBI View Article : Google Scholar : (In Portuguese).
|
|
12
|
Thienemann F, Sliwa K and Rockstroh JK:
HIV and the heart: The impact of antiretroviraltherapy: A global
perspective. Eur Heart J. 46:3538–3546. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Chandwani A and Shuter J:
Lopinavir/ritonavir in the treatment of HIV-1 infection: A review.
Ther Clin Risk Manag. 5:1023–1033. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Portsmouth SD and Scott CJ: The
renaissance of fixed dose combinations: Combivir. Ther Clin Risk
Manag. 4:579–583. 2007.PubMed/NCBI
|
|
15
|
Kline-Fath BM, Bahado-Singh R and Bulas
DI: Advanced assessment of fetal cardiac function. In: Fundamental
and Advanced Fetal Imaging: Ultrasound and MRI. 1st edition. Ed.
Wolters Kluwer Health, pp114-164, 2015.
|
|
16
|
Abuhamad A and Chaoui R: Pulsed Doppler in
fetal echocardiography. In: A Practical Guide to Fetal
Echocardiography-Normal and Abnormal Hearts. 3rd edition. Ed.
Wolters Kluwer Health, pp160-117, 2010.
|
|
17
|
Abuhamad A and Chaoui R: Fetal cardiac
fonction. In: A Practical Guide to Fetal Echocardiography-Normal
and Abnormal Hearts. 3rd edition. Ed. Wolters Kluwer Health,
pp178-199, 2010.
|
|
18
|
Hornberger LK, Lipshultz SE, Easley KA,
Colan SD, Schwartz M, Kaplan S, Starc TJ, Ayres NA, Lai WW, Moodie
DS, et al: Cardiac structure and function in fetuses of mothers
infected with HIV: The prospective PCHIV multicenter study. Am
Heart J. 140:575–584. 2000.PubMed/NCBI View Article : Google Scholar
|
|
19
|
De la Calle M, Rodriguez R, Deiros L and
Bartha L: Fetal cardiac biometry and function in HIV-infected
pregnant women exposed to HAART therapy. Prenat Diagn. 5:453–455.
2015.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Kim HS, Hong YM, Sohn S and Choi JY:
Perinatal changes in size of the fetal great arteries. Korean Circ
J. 10:414–417. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Achiron R, Zimand S, Hegesh J, Lipitz S,
Zalel Y and Rotstein Z: Fetal aortic arch measurements between 14
and 38 weeks' of gestation: In-utero ultrasonographic study.
Ultrasound Obst Gynecol. 15:226–230. 2000.PubMed/NCBI View Article : Google Scholar
|
